Jack Jacobs's Schedule
Parkinson's Disease - Human Disease Reversal - A Biotech Breakthrough (FREE)
Tuesday, April 25, 2023, 11:20 am - 12:05 pm
Parkinson's Disease and other brain disorders affect millions of people, Zhittya has dosed almost 50 patients with its medicine and witnessed a motor skills improvement of 18% up to 85%. This first human clinical data will be shared with attendees. Zhittya's medicine to reverse brain disorders, strokes, multiple sclerosis, and more, is a potential major medical breakthrough. Show More
Register Now to meet me and other top money experts IN PERSON in Las Vegas!
Top 5 Benefits of Attending The MoneyShow
- Talk to Top Money Experts Up Close and in Person
- Discover New Investment Opportunities
- Get Live Market Analysis, Research Reports, & Hands-on Demos
- Network with Other Savvy Investors
- Win Daily Cash Prizes, Shares of Stock, & Swag
Jack Jacobs's Profile
Dr. Jack Jacobs has been involved in the healthcare industry for over 25 years and has extensive expertise in supervising drug manufacturing operations and the design and implementation of preclinical animal trials and US FDA-authorized clinical trials. He started a new department of biological chemistry at Merck and for 15 years worked with Mr. Montano as cardiovascular biotherapeutics' chief scientific officer where Dr. Jacobs oversaw FDA-authorized clinical trials in which FGF-1 was tested in a number of medical indications, including coronary artery disease, diabetic foot ulcers, and peripheral artery disease. He also oversaw the manufacturing of clinical lots of FGF-1 that were used in those clinical studies. Dr. Jacobs received a BS degree from Davidson College and a PhD in molecular biology from Washington University, St. Louis.